BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15270300)

  • 1. [A case of Canavan-Van Bogaert-Bertrand leukodystrophy].
    Mikhaĭlova SV; Zakharova EIu; Bukina AM; Il'ina ES; Pokrovskaia AIa; Fedoniuk ID; Bembeeva RTs; Petrukhin AS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(4):50-4. PubMed ID: 15270300
    [No Abstract]   [Full Text] [Related]  

  • 2. Magnetic resonance imaging in juvenile Canavan disease.
    Toft PB; Geiss-Holtorff R; Rolland MO; Pryds O; Müller-Forell W; Christensen E; Lehnert W; Lou HC; Ott D; Hennig J
    Eur J Pediatr; 1993 Sep; 152(9):750-3. PubMed ID: 8223809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global CNS gene transfer for a childhood neurogenetic enzyme deficiency: Canavan disease.
    Leone P; Janson CG; McPhee SJ; During MJ
    Curr Opin Mol Ther; 1999 Aug; 1(4):487-92. PubMed ID: 11713764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical protocol. Gene therapy of Canavan disease: AAV-2 vector for neurosurgical delivery of aspartoacylase gene (ASPA) to the human brain.
    Janson C; McPhee S; Bilaniuk L; Haselgrove J; Testaiuti M; Freese A; Wang DJ; Shera D; Hurh P; Rupin J; Saslow E; Goldfarb O; Goldberg M; Larijani G; Sharrar W; Liouterman L; Camp A; Kolodny E; Samulski J; Leone P
    Hum Gene Ther; 2002 Jul; 13(11):1391-412. PubMed ID: 12162821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular basis of Canavan disease.
    Matalon R; Michals-Matalon K
    Eur J Paediatr Neurol; 1998; 2(2):69-76. PubMed ID: 10724099
    [No Abstract]   [Full Text] [Related]  

  • 6. Leukodystrophy with multiple beaded periventricular cysts: unusual cranial MRI results in Canavan disease.
    Drenckhahn A; Schuelke M; Knierim E
    J Inherit Metab Dis; 2015 Sep; 38(5):983-4. PubMed ID: 25647544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical MRI findings in Canavan disease: a patient with a mild course.
    Yalcinkaya C; Benbir G; Salomons GS; Karaarslan E; Rolland MO; Jakobs C; van der Knaap MS
    Neuropediatrics; 2005 Oct; 36(5):336-9. PubMed ID: 16217711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in Canavan disease.
    Matalon R; Michals-Matalon K
    Adv Pediatr; 1999; 46():493-506. PubMed ID: 10645473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homozygosity for mutation G212A of the gene for aspartoacylase is associated with atypical form of Canavan's disease.
    Velinov M; Zellers N; Styles J; Wisniewski K
    Clin Genet; 2008 Mar; 73(3):288-9. PubMed ID: 18070137
    [No Abstract]   [Full Text] [Related]  

  • 10. Uncoupling N-acetylaspartate from brain pathology: implications for Canavan disease gene therapy.
    von Jonquieres G; Spencer ZHT; Rowlands BD; Klugmann CB; Bongers A; Harasta AE; Parley KE; Cederholm J; Teahan O; Pickford R; Delerue F; Ittner LM; Fröhlich D; McLean CA; Don AS; Schneider M; Housley GD; Rae CD; Klugmann M
    Acta Neuropathol; 2018 Jan; 135(1):95-113. PubMed ID: 29116375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restoration of aspartoacylase activity in CNS neurons does not ameliorate motor deficits and demyelination in a model of Canavan disease.
    Klugmann M; Leichtlein CB; Symes CW; Serikawa T; Young D; During MJ
    Mol Ther; 2005 May; 11(5):745-53. PubMed ID: 15851013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemistry and molecular biology of Canavan disease.
    Matalon R; Michals-Matalon K
    Neurochem Res; 1999 Apr; 24(4):507-13. PubMed ID: 10227683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between enzyme properties and disease progression in Canavan disease.
    Zano S; Wijayasinghe YS; Malik R; Smith J; Viola RE
    J Inherit Metab Dis; 2013 Jan; 36(1):1-6. PubMed ID: 22850825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restricted diffusion in Canavan disease.
    Srikanth SG; Chandrashekar HS; Nagarajan K; Jayakumar PN
    Childs Nerv Syst; 2007 Apr; 23(4):465-8. PubMed ID: 17219235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of Canavan disease: the first biochemically proven case in a Japanese girl.
    Hamaguchi H; Nihei K; Nakamoto N; Ezoe T; Naito H; Hara M; Yokota K; Inoue Y; Matsumoto I
    Brain Dev; 1993; 15(5):367-71. PubMed ID: 8279652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of NAA-synthesis in the human brain in vivo: Canavan's disease, Alzheimer's disease and schizophrenia.
    Harris K; Lin A; Bhattacharya P; Tran T; Wong W; Ross B
    Adv Exp Med Biol; 2006; 576():263-73; discussion 361-3. PubMed ID: 16802718
    [No Abstract]   [Full Text] [Related]  

  • 17. Atypical clinical and radiological course of a patient with Canavan disease.
    Sarret C; Boespflug-Tanguy O; Rodriguez D
    Metab Brain Dis; 2016 Apr; 31(2):475-9. PubMed ID: 26586007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary treatment proposed for Canavan's disease.
    Chen V
    Lancet Neurol; 2005 May; 4(5):273. PubMed ID: 15861552
    [No Abstract]   [Full Text] [Related]  

  • 19. [Canavan disease or N-acetyl aspartic aciduria: a case report].
    Boughamoura L; Chaabane F; Tilouche S; Chabchoub I; Kabachi N; Tlili K; Yacoub M; Essoussi AS
    Arch Pediatr; 2007 Feb; 14(2):173-6. PubMed ID: 17196380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Juvenile Canavan Disease: A Leukodystrophy without White Matter Changes.
    Jauhari P; Saini L; Chakrabarty B; Kumar A; Gulati S
    Neuropediatrics; 2018 Dec; 49(6):420-421. PubMed ID: 30304741
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.